Home > Healthcare & Medical Devices > Heart-lung Machine Market

Heart-lung Machine Market - By Type (Single Roller Pump, Double Roller Pump), By Application (Cardiac Surgeries, Lung Surgeries, Acute Respiratory Failure Treatment), By End-use, & Forecast, 2023 – 2032

  • Report ID: GMI6060
  • Published Date: Jun 2023
  • Report Format: PDF

Heart-lung Machine Industry Analysis

Heart-Lung Machine Market size was valued at USD 343.2 million in 2022 and is projected to expand at over 4.3% CAGR from 2023 to 2032, owing to increasing prevalence of cardiovascular disorders, coupled with rising geriatric population base. Technological advancements pertaining to heart-lung machine and rising number of transplant surgeries is augmenting the product acceptance rate. Increasing awareness and initiatives to cater to appropriate diagnostic treatments and clinical benefits offered by heart-lung machines will propel the market growth.


Heart-Lung Machine Market

To get more details on this report: Request Free Sample PDF

Additionally, developing countries are emphasizing the expansion of healthcare infrastructure and an increase in the number of specialized cardiac centers, subsequently boosting the heart-lung machine market. Technological advancements, such as the development of miniaturized and portable systems, improved biocompatibility of components, and enhanced monitoring capabilities, will improve the efficiency of cardiac surgeries. Therefore, with the increasing healthcare expenditure, growing disposable income, aging population, and rising adoption of heart-lung machines.

Heart-lung machine, also known as a cardiopulmonary bypass (CPB) machine, is a medical device used for open-heart surgeries to temporarily take over the functions of the heart and lungs. The heart-lung machine performs the essential tasks of oxygenating the blood, removing carbon dioxide, and circulating the oxygenated blood back into the patient's body.

However, high cost of heart-lung machine can pose a significant challenge and impede the market demand. Heart-lung machines are highly sophisticated medical devices that require advanced technology and engineering. They incorporate intricate components, such as pumps, oxygenators, and monitoring systems, which contribute to their high production costs. The initial investment required to purchase heart-lung machine, especially those with advanced features and specifications, can result in financial challenges for healthcare facilities those with limited budgets. For instance, the cost of heart-lung machine can range between USD 10,000 to USD 50,000 and can vary according to the technology used in these machines.

Additionally, these machines require regular maintenance, calibration, and replacement of components to ensure their proper functioning and safety. The cost of maintenance and servicing can add up over time, further increasing the overall cost of ownership. The heart-lung machine market growth can be hindered in developing economies having comparatively low-income levels attributed to the high costs of these machines. Thus, the high-end pricing associated with advanced heart-lung machines may drive down the acceptance rate of these devices.

COVID-19 Impact

The recent outbreak of COVID-19 had negatively influenced the heart-lung machines industry revenue, specifically during the initial phase of 2020. The coronavirus outbreak proliferated the disease burden and hampered several global businesses including the healthcare sector, during the pandemic phase. These conditions severely impacted the heart-lung machines market size. Several hospitals and healthcare facilities globally experienced a significant decline in patient visits for diagnosis and treatment of cardiovascular and other chronic diseases during the pandemic. As a result, elective surgeries, including cardiac procedures that require the use of heart-lung machines, were postponed or canceled. This reduction in surgical volume has directly affected the demand for heart-lung machines and has resulted in a decline in their utilization.

The pandemic has disrupted global supply chains, affecting the manufacturing and distribution of medical devices, including heart-lung machines. Heart-lung machines require close monitoring, maintenance, and adherence to strict infection control protocols to ensure patient safety. However, owing to new standard operating protocols, close contact surgical procedures were limited or postponed amid the transmission of coronavirus. Although later the market recovered, thereby mitigating the initial impact. Furthermore, as the number of COVID-19 infected patients significantly decreased and several healthcare facilities resumed delivering healthcare services, the procedural volume gradually returned to pre-pandemic levels.

Heart-lung Machine Market Trends

Increasing prevalence of cardiovascular diseases is anticipated to increase the adoption of heart-lung machine globally. Cardiovascular diseases, such as coronary artery disease, heart failure, and valvular heart disease, are becoming increasingly common globally. The aging population, sedentary lifestyles, unhealthy diets, and other risk factors contribute to the rising incidence of these diseases. For instance, according to the NCBI data, in 2021, around 400,000 CABG surgeries are performed each year in America and is expected to increase in the near future. Heart-lung machines are essential for performing open-heart surgeries, including coronary artery bypass grafting (CABG), valve repair/replacement, and congenital heart defect corrections.

Advancements in surgical techniques and technologies have expanded the scope of cardiac surgeries, making them safer and more feasible for a broader range of patients. These advancements include minimally invasive procedures, robotic-assisted surgeries, and transcatheter interventions. The prevalence of congenital heart diseases in infants and children necessitates the use of heart-lung machines to provide temporary support to the heart and lungs during complex procedures. Heart-lung machines have proven effective and efficient in several cardiovascular surgeries, thereby augmenting the product demand.

Heart-lung Machine Type Segmentation

Heart-lung Machine Market Size, By Type

To get more details on this report: Request Free Sample PDF

The single roller pump segment held over 60% of the heart-lung machine market share in 2022, due to several clinical benefits offered by single roller pump heart-lung machine. These machines offers several benefits in cardiac surgery and cardiopulmonary support. Single roller pump heart-lung machines propels the blood through the circuit, eliminating the need for complex mechanisms. These machines often incorporate safety features to ensure patient well-being during cardiopulmonary bypass

Safety mechanisms, such as bubble detectors, air removal systems, pressure alarms, and occlusion sensors, help monitor and control the flow of blood, ensuring the absence of air or obstructions that could potentially harm the patient. Single roller pump heart-lung machines minimize the risk of hemolysis by maintaining uniform blood flow without subjecting the blood cells to excessive mechanical stress or shear forces.

Heart-lung Machine Application Segmentation

The cardiac surgeries segment dominated the heart-lung machine market with USD 139 million in 2022, attributed to increasing demand for heart-lung machines for the surgeries and diagnosis & treatment of several cardiac disorders. For instance, according to the WHO data, in 2021, around 17.9 million people globally were estimated to face mortality due to some form of cardiovascular disorder.

Heart-lung machines play a crucial role in cardiac surgeries and contribute to life-saving surgeries performed by healthcare professionals. These machines temporarily taking over the functions of the heart and lungs and provide vital cardiopulmonary support by maintaining oxygenation and circulation of the patient's blood. Heart-lung machines incorporate oxygenators that efficiently oxygenate the patient's blood, removing carbon dioxide and providing oxygen-rich blood to the body.

These machines minimize organ ischemia and reduces the risk of tissue damage and supports organ function by ensuring continuous blood flow and oxygenation during the procedure. Therefore, heart-lung machines provide critical support in cardiac surgeries, allowing surgeons to perform complex procedures with enhanced precision and patient safety, thereby contributing to the overall heart-lung machines market revenue.

Heart-lung Machine End-use Segmentation

Heart-lung Machine Market Share, By End-use,

To get more details on this report: Request Free Sample PDF

The heart-lung machine market size from hospitals and clinics segment was reached USD 147 million in 2022. High adoption rate of advanced heart-lung machine offering enhanced therapeutic outcomes and convenient surgical procedures would surge the patient preference for hospital setting. Increasing admissions with chronic disorders and growing disease related awareness initiatives along with the availability of highly skilled healthcare practitioners are some additional aspects that are fueling the expansion of the hospitals and clinics segment positively.

Technological advancements in cardiac care, including surgical techniques and devices, have expanded the scope of interventions and surgeries performed in hospitals. Additionally, aging population is more susceptible to cardiovascular diseases and related complications, leading to increased hospital admissions. Thus, availability and accessibility to advanced heart-lung machines and better treatment & diagnosis coupled with the rising prevalence of chronic ailments will surge patient visits to hospitals and clinics.

Heart-lung Machine Regional Analysis

North America Heart-lung Machine Market Size,

North America heart-lung machine market is predicted to reach USD 141 million by 2032, on account of numerous variables including the presence of key companies, an increasing prevalence of cardiovascular diseases, and rising awareness regarding the benefits of heart-lung machines among others. Growing number of organ transplant surgeries have fostered the demand for heart-lung machines in the region. For instance, according to the U.S. Department of Health & Human Services, in 2021, around 41,000 organ transplant surgeries were performed in the U.S.

Heart-lung machines enable the safe and successful transplantation of vital organs, supporting patient outcomes and extending life-expectancy among patients. Development of sophisticated heart-lung machines with enhanced features, safety mechanisms, and monitoring capabilities have increased the product adoption rate in North America. As the incident cases of chronic ailment continues to rise in the region, the demand for efficient, proven, and effective heart-lung machines is projected to propel significantly. Thus, supporting initiatives aimed at improving healthcare outcomes, rising healthcare expenditure and increasing disease prone population would drive the regional revenue share positively.

Heart-lung Machine Industry Leaders

Some of the major companies operating in the heart-lung machine market are Braile Biomedica, Edwards Lifesciences Corp., ELITE LIFECARE, Eurosets Srl, Fresenius Medical Care AG and Co. KGaA, Getinge AB, Heart Care India Co., Hemovent GmbH, Jarvik Heart Inc., Koninklijke Philips NV, LivaNova Plc, Medtronic Plc, Nipro Corporation, Palex Medical SA, RAUMEDIC AG, Terumo Corporation.

These leading companies are implementing advanced technologies to cater to the large unmet needs of the consumers. These companies focus on strategic partnerships, new product launch & commercialization for market expansion. Furthermore, these companies are heavily investing in research that allows them to introduce innovative products and garner maximum revenue in the market.

Heart-lung Machine Industry News:

  • In March 2023, LivaNova announced that they had received the U.S. FDA 510(k) clearance for their Essenz heart-lung machine intended for cardiopulmonary bypass (CPB) procedures. This machine is incorporated with advanced cable management and components for smooth user interface and better clinical results. This regulatory approval helped the company to enhance their R&D capabilities and increase their business revenue.
  • In April 2021, Getinge AB announced the availability of HL 40 heart-lung machine in several countries across Europe. This machine provides controlled circulation of oxygenated blood during complex cardiac surgical interventions. This strategic move helped the company to expand their geographic presence and increase their customer base.

This heart-lung machine market research report includes an in-depth coverage of the industry with estimates & forecast in terms of revenue (USD Million) and volume (Units) from 2018 to 2032, for the following segments:

Click here to Buy Section of this Report

Market, By Type

  • Single Roller Pump
  • Double Roller Pump

Market, By Application

  • Cardiac Surgeries
  • Lung Surgeries
  • Acute Respiratory Failure Treatment
  • Others

Market, By End-use

  • Hospitals and Clinics
  • Ambulatory Surgical Centers
  • Others

The above information has been provided for the following regions and countries:

  • North America
    • U.S.
    • Canada
  • Europe
    • Germany
    • UK
    • France
    • Spain
    • Italy
    • Poland
    • Sweden
    • The Netherlands
  • Asia Pacific
    • China
    • Japan
    • India
    • Australia
    • South Korea
    • Indonesia
    • Thailand
    • Philippines
  • Latin America
    • Brazil
    • Mexico
    • Argentina
    • Colombia
    • Chile
    • Peru
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE
    • Israel
    • Egypt
    • Turkey


Authors: Rupali Swain, Shishanka Wangnoo

Frequently Asked Questions (FAQ) :

The market size of heart-lung machine was reached USD 343 million in 2022 and will reach over USD 520 million by 2032, due to increasing prevalence of cardiovascular disorders, coupled with rising number of transplant surgeries.

The single roller pump held a dominant market share of around 60% in 2022, owing to several clinical benefits offered by single roller pump heart-lung machine such as propelling blood through the circuit, eliminating the need for complex mechanisms.

North America market will reach around USD 141 million by 2032, attributable to the presence of key players in the region, an increasing prevalence of cardiovascular diseases, and rising awareness regarding the benefits of heart-lung machines.

Braile Biomedica, Edwards Lifesciences Corp., ELITE LIFECARE, Eurosets Srl, Getinge AB, Heart Care India Co., Hemovent GmbH, Jarvik Heart Inc., Koninklijke Philips NV, LivaNova Plc, and Medtronic Plc.

Buy Now

Access to only 1 person; cannot be shared; cannot be printed
Access for 2 to 5 users only within same department of one company
Access to a company wide audience; includes subsidiary companies or other companies within a group of companies

Premium Report Details

  • Base Year: 2022
  • Companies covered: 16
  • Tables & Figures: 363
  • Countries covered: 30
  • Pages: 180
Inquiry Before Buying

Budget constraints? Get in touch with us for special pricing

Request Discount